Zobrazeno 1 - 10
of 10
pro vyhledávání: '"María de Oña Navarro"'
Publikováno v:
Medicina Clínica. 157:213-214
Publikováno v:
Medicina Clínica (English Edition). 157:213-214
Autor:
Marta E. Alvarez-Argüelles, Jose Antonio Boga Riveiro, María Agustina Alonso Álvarez, María de Oña Navarro, Zulema Pérez Martínez, Susana Rojo-Alba, Julián Rodríguez Súarez, Santiago Melón García, Álvaro Leal Negredo
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
Human Parainfluenzaviruses (PIVs) account for a significant proportion of viral acute respiratory infections (ARIs) in children, and are also associated with morbidity and mortality in adults, including nosocomial infections. This work aims to descri
Autor:
Jose Antonio-Boga, Sonia Pérez-Castro, Marta E. Alvarez-Argüelles, Maria Luisa Junquera-Llaneza, Santiago Melón-García, Susana Rojo-Alba, Magdalena Torrens-Muns, María de Oña-Navarro
Publikováno v:
Journal of Virological Methods. 222:95-102
Background and purpose Surrogate markers such as viral load are necessary to follow the evolution of disease resulting from infection with Human Papilloma virus (HPV), especially in this era of vaccination. As such, this paper uses the automated syst
Autor:
María Ángeles Marcos Maeso, Mercedes Pérez-Ruiz, Jordi Reina, José María Navarro-Marí, María de Oña Navarro, Carlos Gustavo Cilla Eguiluz, Juan Carlos Galán Montemayor
Publikováno v:
Enfermedades Infecciosas Y Microbiologia Clinica
Coinciding with the pandemic wave of the influenza A(H1N1)pdm09 virus, other respiratory viruses have co-circulated in our area and were responsible for many acute respiratory infections and influenza-like illness (ILI). Apart from the pandemic virus
Autor:
Ana Fernández-Verdugo, Marta E. Alvarez-Argüelles, Santiago Melón García, Jose Antonio Boga Riveiro, María de Oña Navarro
Publikováno v:
Enfermedades Infecciosas Y Microbiologia Clinica
Introduction Although new influenza virus (IAn/H1N1) infections are mild and indistinguishable from any other seasonal influenza virus infections, there are few data on comparisons of the clinical features of infection with (IAn/H1N1) and with other
Autor:
Silvia Alvárez Alvárez, Marta E. Alvarez-Argüelles, María de Oña Navarro, Santiago Melón García
Publikováno v:
Piel. 32:180-181
Publikováno v:
Medicina Clínica (English Edition). 145:e17-e18
Publikováno v:
Medicina Clínica. 145:e17-e18
Autor:
Santiago Melón, Beatriz Iglesias, María J. Bernardo, María de Oña Navarro, José L. Rodriguez-Lambert, E. Gómez, Susana Méndez, Ana Palacio
Publikováno v:
Transplant International. 15
Ganciclovir (GCV) prophylaxis or pre-emptive therapy significantly reduce the rate of cytomegalovirus (CMV) disease and viremia, but increase the potential for emergence of ganciclovir-resistant CMV strains. The inhibitor concentration at 50% (IC(50)